Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: Effects of angiotensin converting enzyme inhibition

Diabetologia

Volumn 45, Issue 11, 2002, Pages 1572-1576

  Langham, R ^a,b,c,d   Kelly, D ^a,b,c,d   Cox, A ^a,b,c,d   Thomson, N ^a,b,c,d   Holthofer H ^a,b,c,d   Zaoui, P ^a,b,c,d   Pinel, N ^a,b,c,d   Cordonnier, D ^a,b,c,d   Gilbert, R ^a,b,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Angiotensin converting enzyme inhibition; Diabetic nephropathy; Nephrin; Podocyte; Proteinuria

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MEMBRANE PROTEIN; MESSENGER RNA; NEPHRIN; PERINDOPRIL; PLACEBO; CREATININE; GLYCOSYLATED HEMOGLOBIN; PROTEIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DRUG EFFECT; ENZYME INHIBITION; GLOMERULUS FILTRATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY CORTEX SLICE; MACROMOLECULE; NEPHRECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BIOPSY; BLOOD PRESSURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; URINE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOPSY; BLOOD PRESSURE; CREATININE; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IN SITU HYBRIDIZATION; MEMBRANE PROTEINS; PERINDOPRIL; PLACEBOS; PROTEINS; PROTEINURIA;

EID: 0036433059     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0946-y     Document Type: Article

References (34)

1. Mogensen CE, Schmitz O (1988) The diabetic kidney: From hyperfiltration and microalbuminuria to end-stage renal failure. Med Clin North Am 72: 1465-1492
2. Border WA, Yamamoto T, Noble NA (1996) Transforming growth factor-β in diabetic nephropathy. Diabetes Metab Rev 12: 309-339
3. Striker GE, Eastman RD, Striker LJ (1996) Diabetic nephropathy - Molecular analysis of extracellular matrix and clinical studies update. Nephrol Dial Transplant 11: 58-61
4. McLennan SV, Fisher EJ, Yue DK, Turtle JR (1994) High glucose concentration causes a decrease in mesangium degradation. Diabetes 43: 1041-1045
5. Kestila M, Lenkkeri U, Mannikko M et al. (1998) Positionally cloned gene for a novel glomerular protein-nephrin - Is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582
6. Benigni A, Tomasoni S, Gagliardini E et al. (2001) Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12: 941-948
7. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z (2001) Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 44: 874-877
8. Kasiske B, Kalil R, Ma J, Liao M, Keane W (1993) Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118: 129-138
9. Cordonnier DJ, Pinel N, Barro C et al. (1999) Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J Am Soc Nephrol 10: 1253-1263
10. Scholey JW, Miller PL, Rennke HG, Meyer TW (1989) Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy. Kidney Int 36: 816-822
11. Jonker A, Boer PA de, Hoff MJ van den, Lamers WH, Moorman AF (1997) Towards quantitative in situ hybridization. J Histochem Cytochem 45: 413-423
12. Kelly DJ, Gilbert RE, Cox AJ, Soulis T, Jerums G, Cooper ME (2001) Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol 12: 2098-2107
13. 33P. J Histochem Cytochem 41: 1767-1773
14. Mulder H, Ahrén B, Sundler F (1996) Applications of in situ hybridization and immunocytochemistry for localization and quantification of gene expression-A lesson from islet amyloid peptide. In: Gu J (ed) Analytical Morphology- Theory, Applications and Protocols. Eaton Publishing, Natick, pp 115-137
15. Patrakka J, Ruotsalainen V, Ketola I et al. (2001) Expression of nephrin in pediatric kidney diseases. J Am Soc Nephrol 12: 289-296
16. Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456
17. Tryggvason K (1999) Unraveling the mechanisms of glomerular ultrafiltration: Nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 10: 2440-2445
18. Doublier S, Ruotsalainen V, Salvidio G et al. (2001) Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 158: 1723-1731
19. Furness PN, Hall LL, Shaw JA, Pringle JH (1999) Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant 14: 1234-1237
20. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462
21. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) (1997) Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-1863
22. Lewis EJ, Hunsicker LG, Clarke WR et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860
23. Brenner BM, Cooper ME, Zeeuw D de et al. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869
24. Ichikawi I, Harris RC (1991) Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int 40: 583-596
25. Johnston CI, Risvanis J, Naitoh M, Tikkanen I (1998) Mechanism of progression of renal disease - Current hemodynamic concepts. J Hypertens 16: S3-S7
26. Inagami T (1999) Molecular biology and signaling of angiotensin receptors: An overview. J Am Soc Nephrol 10 [Suppl 11]: S2-S7
27. Sharma M, Sharma R, Greene AS, McCarthy ET, Savin VJ (1998) Documentation of angiotensin II receptors in glomerular epithelial cells. Am J Physiol 274: F623-F627
28. Gloy J, Henger A, Fischer KG et al. (1998) Angiotensin II modulates cellular functions of podocytes. Kidney Int 54: S168-S170
29. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G (1990) Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541-549
30. Born J van den, Gunnarsson K, Bakker MA et al. (1995) Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 270: 31303-31309
31. Russo LM, Bakris GL, Comper WD (2002) Renal handling of albumin: A critical review of basic concepts and perspective. Am J Kidney Dis 39: 899-919
32. Rennke HG (1994) How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int [Suppl] 45: S58-S63
33. Steffes MW, Schmidt D, McCrery R, Basgen JM, Group ID (2001) Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113
34. Kriz W (1996) Progressive renal failure - Inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11: 1738-1742